Mobara, Japan

Yukichi Kawai

This inventor holds 1 USPTO granted patent. Top assignee: Mitsui Toatsu Chemicals, Incorporated. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yukichi Kawai. Retrieved from https://idiyas.com/inventor/yukichi-kawai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yukichi Kawai: Innovator in Quinoline Derivative Fumarates

Introduction

Yukichi Kawai is a notable inventor based in Mobara, Japan. He has made significant contributions to the field of chemistry, particularly in the development of quinoline derivative fumarates. His work focuses on enhancing the effectiveness of carcinostatic agents.

Latest Patents

Kawai holds a patent for "Quinoline derivative fumarates - Compounds having an activity to stimulate the carcinostatic effect of carcinostatic agents." This invention aims to improve the oral absorbability and solubility of these compounds in water without compromising their therapeutic effects. He has 1 patent to his name.

Career Highlights

Yukichi Kawai is associated with Mitsui Toatsu Chemicals, Incorporated, where he applies his expertise in chemical compounds. His work has contributed to advancements in cancer treatment methodologies.

Collaborations

Kawai has collaborated with notable colleagues such as Nobuyuki Fukazawa and Osamu Yano. Their combined efforts have furthered research in the field of carcinostatic agents.

Conclusion

Yukichi Kawai's innovative work in quinoline derivative fumarates showcases his commitment to improving cancer treatment options. His contributions are valuable to the scientific community and the ongoing fight against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…